59.3
Cocrystal Pharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
40.2
FY23:
29.1
FY24:
11.6
FY25:
8.13
(positive)
Change from FY21 to FY25
millions USD
FY21:
20.1
FY22:
0.66
FY23:
2.17
FY24:
1.88
FY25:
1.58
Total assets
Change from FY21 to FY25
millions USD
FY21:
79.4
FY22:
40.8
FY23:
31.3
FY24:
13.5
FY25:
9.71
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.55
FY22:
1.22
FY23:
3.26
FY24:
2.43
FY25:
2.21
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.30
FY22:
0.06
FY23:
1.61
FY24:
1.51
FY25:
1.17
(positive)
Change from FY21 to FY25
millions USD
FY21:
77.5
FY22:
39.6
FY23:
26.4
FY24:
9.52
FY25:
6.33
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
79.4
FY22:
40.8
FY23:
31.3
FY24:
13.5
FY25:
9.71
All amounts in millions USD